467 related articles for article (PubMed ID: 19631025)
1. Experimental rat models to study the metabolic syndrome.
Aleixandre de Artiñano A; Miguel Castro M
Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
[TBL] [Abstract][Full Text] [Related]
3. Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome.
Huber M; Heiduschka P; Ziemssen F; Bolbrinker J; Kreutz R
Hypertens Res; 2011 Jan; 34(1):103-12. PubMed ID: 20927114
[TBL] [Abstract][Full Text] [Related]
4. Rat models of the metabolic syndrome.
Tofovic SP; Jackson EK
Methods Mol Med; 2003; 86():29-46. PubMed ID: 12886760
[No Abstract] [Full Text] [Related]
5. Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.
Comte C; Bellenger S; Bellenger J; Tessier C; Poisson JP; Narce M
Biochimie; 2004 Nov; 86(11):799-806. PubMed ID: 15589689
[TBL] [Abstract][Full Text] [Related]
6. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.
Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P
Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453
[TBL] [Abstract][Full Text] [Related]
7. The role of obesity, hypertension and diet in diabetes and its complications in the Spontaneous Hypertensive/NIH-corpulent rat.
Michaelis OE; Carswell N; Velasquez MT; Hansen CT
Nutrition; 1989; 5(1):56-9. PubMed ID: 2520260
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
9. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
Sugimoto K; Rashid IB; Kojima K; Shoji M; Tanabe J; Tamasawa N; Suda T; Yasujima M
Diabetes Metab Res Rev; 2008; 24(8):642-50. PubMed ID: 18973207
[TBL] [Abstract][Full Text] [Related]
10. High susceptibility of obese hypertensive SHRSP.Z-Lepr(fa) /IzmDmcr rats to lipid deposition in the mesenteric artery.
Kunimasa K; Yoshitomi H; Miura C; Mori H; Tsuchikura S; Ikeda K; Gao M; Yamori Y; Mori M
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1102-4. PubMed ID: 20726991
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel congenic strain of diabetic fatty (WBN/Kob-Lepr(fa)) rat.
Akimoto T; Nakama K; Katsuta Y; Zhang XJ; Ohsuga M; Ishizaki M; Sawai N; Ozawa H
Biochem Biophys Res Commun; 2008 Feb; 366(2):556-62. PubMed ID: 18068663
[TBL] [Abstract][Full Text] [Related]
12. Use of rat genomics for investigating the metabolic syndrome.
Pravenec M
Methods Mol Biol; 2010; 597():415-26. PubMed ID: 20013249
[TBL] [Abstract][Full Text] [Related]
13. Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension.
Takemori K; Kimura T; Shirasaka N; Inoue T; Masuno K; Ito H
Life Sci; 2011 Jun; 88(25-26):1088-94. PubMed ID: 21514307
[TBL] [Abstract][Full Text] [Related]
14. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity.
Winocur G; Greenwood CE; Piroli GG; Grillo CA; Reznikov LR; Reagan LP; McEwen BS
Behav Neurosci; 2005 Oct; 119(5):1389-95. PubMed ID: 16300445
[TBL] [Abstract][Full Text] [Related]
15. A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
Qi NR; Wang J; Zidek V; Landa V; Mlejnek P; Kazdová L; Pravenec M; Kurtz TW
Hypertension; 2005 May; 45(5):1004-11. PubMed ID: 15809359
[TBL] [Abstract][Full Text] [Related]
16. Mechanism linking insulin resistance to defective thermogenesis in brown adipose tissue of obese diabetic SHR/N-cp rats.
Marette A; Tulp OL; Bukowiecki LJ
Int J Obes; 1991 Dec; 15(12):823-31. PubMed ID: 1665483
[TBL] [Abstract][Full Text] [Related]
17. Neonatal streptozotocin-induced glucose intolerance: different consequences in Lyon normotensive and hypertensive rats.
Emonnot L; Cohen R; Lo M
J Hypertens; 2007 Feb; 25(2):429-38. PubMed ID: 17211251
[TBL] [Abstract][Full Text] [Related]
18. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome.
Deushi M; Nomura M; Kawakami A; Haraguchi M; Ito M; Okazaki M; Ishii H; Yoshida M
FEBS Lett; 2007 Dec; 581(29):5664-70. PubMed ID: 18022391
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: comparison of the two commonly used animal models.
Oron-Herman M; Kamari Y; Grossman E; Yeger G; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Am J Hypertens; 2008 Sep; 21(9):1018-22. PubMed ID: 18566592
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia and diabetes: animal models.
Mathé D
Diabete Metab; 1995 Apr; 21(2):106-11. PubMed ID: 7621969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
